Key highlights
07 July 2023 – 1 mins read
LinkedIn
Twitter
Facebook
Primary Biliary Cholangitis (PBC): Looking Beyond the Liver
“Symptom burden is the main issue for the patient.”– Professor Andreas Kremer, Hepatologist of the University of Zurich Hospital
Explore more by category
Showing: 1 – 5 of 97 stories
31 October 2023 – 2 mins read
Innovating for people living with primary biliary cholangitis
At Ipsen we have been focused on developing new and innovative treatments for rare diseases for many years in endocrinology, rare bone disease and more recently in rare liver disease. This focus continues to be a core part of our…
29 October 2023 – 1 mins read
Rising to the challenge, life after stroke
Globally, stroke is the 2nd leading cause of death worldwide, in addition to being the 3rd leading cause of combined death and disability across the world, with approximately 1 in 4 people over the age of 25 expected to experience…
29 October 2023 – 0 mins read
27 October 2023 – 1 mins read
Ipsen is officially recognized as a great place to work worldwide
At Ipsen we are incredibly proud of the way that our culture is evolving. Lived through our Ipsen Way of Being and supporting our business strategy, our team is demonstrating internally and externally our culture of collaboration and excellence and…
23 October 2023 – 1 mins read
2023 year to date and third-quarter sales results
Ipsen has published its year to date and third-quarter sales results on 26 October 2023 at 7am CET.
